Putnam Investments’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,735
Closed -$1.11M 1413
2015
Q4
$1.11M Sell
4,735
-80
-2% -$18.8K ﹤0.01% 1134
2015
Q3
$761K Buy
+4,815
New +$761K ﹤0.01% 1232
2014
Q3
Sell
-1,836
Closed -$449K 1503
2014
Q2
$449K Buy
1,836
+2
+0.1% +$489 ﹤0.01% 1341
2014
Q1
$486K Sell
1,834
-26,023
-93% -$6.9M ﹤0.01% 1360
2013
Q4
$10.1M Sell
27,857
-20,108
-42% -$7.3M 0.02% 451
2013
Q3
$25.5M Buy
47,965
+13,978
+41% +$7.43M 0.07% 275
2013
Q2
$7.96M Buy
+33,987
New +$7.96M 0.02% 491